149 related articles for article (PubMed ID: 11127579)
41. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
[TBL] [Abstract][Full Text] [Related]
42. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK
Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
[TBL] [Abstract][Full Text] [Related]
44. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
45. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
[TBL] [Abstract][Full Text] [Related]
47. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
48. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
49. Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis.
Yamada M; Kuwano K; Maeyama T; Yoshimi M; Hamada N; Fukumoto J; Egashira K; Hiasa K; Takayama K; Nakanishi Y
J Clin Pathol; 2007 Aug; 60(8):916-20. PubMed ID: 17018685
[TBL] [Abstract][Full Text] [Related]
50. Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.
Chung IM; Kim J; Pak YK; Jang Y; Yang WI; Han I; Park SJ; Park SW; Huh J; Wight TN; Ueno H
Int J Cardiol; 2010 Dec; 145(3):468-75. PubMed ID: 20053468
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice.
Nagashio Y; Ueno H; Imamura M; Asaumi H; Watanabe S; Yamaguchi T; Taguchi M; Tashiro M; Otsuki M
Lab Invest; 2004 Dec; 84(12):1610-8. PubMed ID: 15502860
[TBL] [Abstract][Full Text] [Related]
52. Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats.
Robertson JV; Golesic E; Gauldie J; West-Mays JA
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):308-18. PubMed ID: 19696167
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit.
Jester JV; Barry-Lane PA; Petroll WM; Olsen DR; Cavanagh HD
Cornea; 1997 Mar; 16(2):177-87. PubMed ID: 9071531
[TBL] [Abstract][Full Text] [Related]
54. Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury.
Hogaboam CM; Simpson KJ; Chensue SW; Steinhauser ML; Lukacs NW; Gauldie J; Strieter RM; Kunkel SL
Gene Ther; 1999 Apr; 6(4):573-84. PubMed ID: 10476217
[TBL] [Abstract][Full Text] [Related]
55. An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system.
Mosedale DE; Grainger DJ
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):125-33. PubMed ID: 10493920
[TBL] [Abstract][Full Text] [Related]
56. [Impact of regenerated silk protein membrane on the cytokine expression of transfected human corneal epithelium cells].
Zhang XF; Liu TL; Sheng WH; Yang JC; Miao JC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):992-8. PubMed ID: 20137417
[TBL] [Abstract][Full Text] [Related]
57. Photocoagulation-induced retinal gliosis is inhibited by systemically expressed soluble TGF-beta receptor type II via adenovirus mediated gene transfer.
Hisatomi T; Sakamoto T; Yamanaka I; Sassa Y; Kubota T; Ueno H; Ohnishi Y; Ishibashi T
Lab Invest; 2002 Jul; 82(7):863-70. PubMed ID: 12118088
[TBL] [Abstract][Full Text] [Related]
58. Gene transfer and kidney disease.
Imai E; Isaka Y; Akagi Y; Kaneda Y; Hori M
J Nephrol; 1998; 11(1):16-9. PubMed ID: 9561480
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization.
Sonoda K; Sakamoto T; Yoshikawa H; Ashizuka S; Ohshima Y; Kishihara K; Nomoto K; Ishibashi T; Inomata H
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2245-51. PubMed ID: 9804132
[TBL] [Abstract][Full Text] [Related]
60. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition.
Kingston PA; Sinha S; David A; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2001 Nov; 104(21):2595-601. PubMed ID: 11714656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
